Abstract:Cancer is one of the leading public health concerns globally; therefore it is required better drugs for treatment. Several strategies have been taken to improve the success of drug discovery. Our strategy is the exploration of organometallic platinum group metal complexes as potential anticancer drugs. Organometallic complexes bearing N-heterocyclic carbene (NHC) ligands are getting attention for therapeutic purposes. Synthesis, structure, and anticancer activities of platinum(II)- and gold(III)-N-heterocyclic carbene complexes supported by proligand 1-methyl-2-(pyridylmethyl)imidazo[1,5-a]pyridin-4-ylium hexafluorophosphate, (1.HPF6) have been described. Two novel isoelectronic and isostructural complexes, viz. [Pt(1)Cl2](2), [Au(1)Cl2][AuCl4] (3), have been synthesized and characterized by a series of spectroscopic techniques. Finally, the square planar geometry of 3 was established by single crystal X-ray diffraction studies. Interestingly, complex 3 possesses Cl--Cl interactions and this is the first organogold bears the same. Molecular docking analysis revealed the highest free binding energy for complex 3 with Human-DNA Topoisomerase. Finally, invitro anticancer studies on breast cancer cell line, MDA-MB231 revealed Au(III)-NHC complex 3 is more potent than Pt(II)-NHC complex 2. therapeutic purposes. Synthesis, structure, and anticancer activities of platinum(II)- and gold(III)-N-heterocyclic carbene complexes supported by proligand 1-methyl-2-(pyridylmethyl)imidazo[1,5-a]pyridin-4-ylium hexafluorophosphate, (1.HPF6) have been described. Two novel isoelectronic and isostructural complexes, viz. [Pt(1)Cl2](2), [Au(1)Cl2][AuCl4] (3), have been synthesized and characterized by a series of spectroscopic techniques. Finally, the square planar geometry of 3 was established by single crystal X-ray diffraction studies. Interestingly, complex 3 possesses Cl--Cl interactions and this is the first organogold bears the same. Molecular docking analysis revealed the highest free binding energy for complex 3 with Human-DNA Topoisomerase. Finally, invitro anticancer studies on breast cancer cell line, MDA-MB231 revealed Au(III)-NHC complex 3 is more potent than Pt(II)-NHC complex 2.

Caffeine derived platinum(II) N -heterocyclic carbene complexes with multiple anti-cancer activities

A multi-target caffeine derived rhodium(i) N-heterocyclic carbene complex: evaluation of the mechanism of action.

Elucidating the Multimodal Anticancer Mechanism of an Organometallic Terpyridine Platinum(II) N-Heterocyclic Carbene Complex against Triple-Negative Breast Cancer In Vitro and In Vivo

Synthesis and anticancer activity of silver(I)-N-heterocyclic carbene complexes derived from the natural xanthine products caffeine, theophylline and theobromine

Novel antitumor dinuclear platinum (II) complexes with a new chiral tetradentate ligand as the carrier group

Synthesis of Novel NHC–Rh Complexes with Anti-Tumor Activity Against MCF-7 Human Breast Cancer Cells

Mixed N‐heterocyclic carbene and benzyl‐, phenethyl‐, and biphenylamine coordinated Pd complexes: Anticancer activities and stereo‐electronic effects

Synthesis and Anticancer Activity of [2-Hydroxy-1,3-diaminopropane-κ2n,n′] Platinum(ii) Complexes

Platinum(II) Terpyridine Anticancer Complexes Possessing Multiple Mode of DNA Interaction and EGFR Inhibiting Activity

Structure-base design to explore the anticancer efficacy of organometallic Pt(II)- and Au(III)-N-heterocyclic carbene (NHC) complexes

Metal-N-heterocyclic carbene complexes as anti-tumor agents

Synthesis and Antitumor Activity of Dinuclear Platinum Complexes with (1(i)R, 1(ii)R, 2(i)R, 2(ii)R)-N-i,N-ii-(1, 3-Phenylenebis(methylene))dicyclohexane-1, 2-diamie as the Ligand

Platinum(II) complexes bearing the simplest olefin ligand: A new class potential for the development of anticancer drugs

Synthesis and anticancer mechanisms of four novel platinum(II) 4′-substituted-2,2′:6′,2′′-terpyridine complexes

Fe(II) Complexes of 2,2':6',2''-Terpyridine Ligands Functionalized with Substituted-Phenyl Groups: Synthesis, Crystal Structures and Anticancer Potential.

Platinum(II) N -heterocyclic carbene complexes arrest metastatic tumor growth

Synthesis, structures, and anticancer potentials of four platinum (II) complexes with benzopyran derivatives targeting mitochondria

Catalytic and Pharmacological Activity

Study on the cytotoxic activity of platinum(II) complexes of (1R,2R)-N(1)-cyclopentyl-1,2-cyclohexanediamine with substituted malonate derivatives.

Synthesis, Characterization, and Catalytic Study of Caffeine-Derived N-heterocyclic Carbene Palladium Complexes

Ferrocene-modified Half-Sandwich Iridium(iii) and Ruthenium(ii) Propionylhydrazone Complexes and Anticancer Application